These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7266416)

  • 21. [Transcutaneous heparin therapy. Experimental histological studies with the effective combination heparin--allantoin--D panthenol].
    Heine H
    Med Welt; 1983 May; 34(20):602-4. PubMed ID: 6877066
    [No Abstract]   [Full Text] [Related]  

  • 22. [Syncumar or low doses of heparin in the prevention of thromboembolism in acute myocardial infarct?].
    Rák K; Misz M; Boda Z; Udvardy M; Pfiegler G
    Orv Hetil; 1981 Nov; 122(46):2871-2. PubMed ID: 7322586
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma heparin levels during and after hysterectomy with low-dose heparin or heparin-dihydroergotamin prophylaxis.
    Briel RC
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):513-23. PubMed ID: 7444864
    [No Abstract]   [Full Text] [Related]  

  • 24. [Vasospasm during thromboembolism prevention using heparin-dihydroergotamine].
    Rumpf KD; van den Berg E; Fröhlich H
    Dtsch Med Wochenschr; 1982 Sep; 107(36):1370-3. PubMed ID: 7117148
    [No Abstract]   [Full Text] [Related]  

  • 25. [Increased wound healing disorders in patients with inguinal hernia caused by administration of antithrombotic agents in the abdominal wall].
    Lemke H; Imhoff M; Löhlein D
    Chirurg; 1994 Aug; 65(8):714-6. PubMed ID: 7956538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ergotism--an important complication of drug thromboembolism prevention].
    Krupp P; Meyer HE
    Dtsch Med Wochenschr; 1982 Jan; 107(1):36. PubMed ID: 7056149
    [No Abstract]   [Full Text] [Related]  

  • 27. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A new method of heparin therapy: subcutaneous administration in thromboembolism].
    Rák K
    Orv Hetil; 1989 Feb; 130(6):295-7. PubMed ID: 2922193
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ergotism--a severe complication of drug prevention of thromboembolism].
    van den Berg E; Walterbusch G
    Dtsch Med Wochenschr; 1982 May; 107(18):716-8. PubMed ID: 7075489
    [No Abstract]   [Full Text] [Related]  

  • 30. Acetylsalicylic acid in combination with dihydroergotamine for preventing thromboembolism.
    Zekert F; Schemper M; Neumann K
    Haemostasis; 1982; 11(3):149-53. PubMed ID: 7095604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Perioperative prevention of thromboembolism in ENT medicine].
    Wilhelm T; Weber BP
    HNO; 1996 Jan; 44(1):31-2. PubMed ID: 8819727
    [No Abstract]   [Full Text] [Related]  

  • 32. Heparins and venous thromboembolism: current practice and future directions.
    Prandoni P
    Thromb Haemost; 2001 Jul; 86(1):488-98. PubMed ID: 11487039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subcutaneous heparin therapy in cardiologic practice].
    Faivre G; Houplon M; Petitier H; Weiller M
    Ann Cardiol Angeiol (Paris); 1969; 18(3):249-55. PubMed ID: 5398615
    [No Abstract]   [Full Text] [Related]  

  • 34. Heparin therapy.
    Ebell MH
    J Fam Pract; 1994 May; 38(5):527-8. PubMed ID: 8195726
    [No Abstract]   [Full Text] [Related]  

  • 35. Heparin therapy for venous thromboembolism.
    Tanaka DJ
    West J Med; 1994 Mar; 160(3):255-6. PubMed ID: 8191765
    [No Abstract]   [Full Text] [Related]  

  • 36. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
    Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy-risk relationship in heparin-dihydroergotamine].
    Rasche H
    Dtsch Med Wochenschr; 1983 Jul; 108(26):1040-1. PubMed ID: 6851906
    [No Abstract]   [Full Text] [Related]  

  • 38. Heparin therapy-part I.
    Caprini JA; Zoellner JL; Weisman M
    Cardiovasc Nurs; 1977; 13(3):13-6. PubMed ID: 585587
    [No Abstract]   [Full Text] [Related]  

  • 39. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Healing of a patient with thromboembolism of the bifurcation of the aorta with a mixture of fibrinolysin and heparin].
    Fesenko IP
    Klin Med (Mosk); 1973 Jan; 51(1):131-2. PubMed ID: 4271811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.